Nucleic Acid Amplification Testing Market, By Type (Polymerase Chain Reaction (PCR) Tests and Isothermal Nucleic Acid Amplification Technology (INAAT) Tests), By Application, By End-use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
|
Report ID
AV4602
|
Published Date
December 2025
|
Pages
399
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Nucleic Acid Amplification testing Market size was valued at US$9,897.45 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.
The global Nucleic Acid Amplification Testing (NAAT) market is witnessing strong growth, driven by the rising prevalence of infectious diseases and continuous advancements in molecular diagnostic technologies. NAAT, recognized for its high sensitivity and specificity, is widely regarded as the gold standard for detecting and quantifying nucleic acids (DNA and RNA), playing a crucial role in diagnosing diseases such as COVID-19, HIV, and tuberculosis. Increasing demand for rapid, decentralized Point-of-Care (POC) testing, coupled with expanding applications in oncology, precision medicine, and genetic disorder diagnostics, is further fueling market expansion. Additionally, government initiatives to strengthen infectious disease surveillance and improve public health outcomes are supporting widespread adoption of NAAT technologies; for example, the World Health Organization and national health agencies have increasingly endorsed NAAT-based testing programs to enhance early detection and containment of viral ou
Nucleic Acid Amplification testing Market- Market Dynamics
Rising Infectious Disease Burden and Public Health Challenges
The increasing prevalence of infectious diseases—including respiratory infections, sexually transmitted infections (STIs), and emerging or re-emerging pathogens—poses significant challenges to global public health, driven by factors such as globalization, urbanization, and climate change. According to the World Health Organization (WHO), around 10.8 million people were diagnosed with tuberculosis (TB) worldwide in 2023, including 6.0 million men, 3.6 million women, and 1.3 million children. In response, Nucleic Acid Amplification Tests (NAAT) have become critical due to their high sensitivity and specificity, enabling the early detection of infections even before symptoms manifest. Early identification facilitates timely treatment, reducing adverse health outcomes and limiting disease transmission, particularly for STIs. Additionally, NAAT is essential for public health surveillance, supporting rapid testing during outbreaks and aiding in controlling the spread of diseases. Its ability to detect new and evolving pathogens makes NAAT a vital tool for publi
Nucleic Acid Amplification testing Market- Segmentation Analysis:
The Global Nucleic Acid Amplification testing Market is segmented on the basis of Type, Application, End-use, and Region.
The global molecular diagnostics market is segmented by type into polymerase chain reaction (PCR) tests, isothermal nucleic acid amplification technology (INAAT) tests, and other specialized molecular tests. PCR tests continue to hold the largest share due to their high sensitivity, versatility, and widespread adoption in diagnostic and research applications, forming the backbone of molecular testing for infectious diseases, oncology, and genetic disorders. INAAT tests are gaining traction for their rapid turnaround times and suitability for point-of-care diagnostics, particularly in regions where healthcare systems emphasize timely testing and decentralized medical services. Government health agencies worldwide, including programs supported by the World Health Organization (WHO) and national health ministries, actively promote molecular testing infrastructure, contributing to sustained demand for both PCR and INAAT technologies.
By application, the market is categorized into infectious disease testing, oncology testing, genetic and mitochondrial disease testing, and other specialized applications. Infectious disease testing dominates the market due to the rising prevalence of viral and bacterial infections, as well as the increasing need for accurate diagnostic solutions to support public health initiatives. Governments globally have invested heavily in molecular diagnostic programs, particularly during and after pandemics, to enhance early detection, surveillance, and outbreak response, resulting in billions of tests performed annually in clinical and public health laboratories. Oncology and genetic disease testing are also growing rapidly, supported by national cancer control programs and genomics initiatives aimed at improving early detection, personalized therapy, and preventive healthcare.
In terms of end use, the market is divided into central and reference laboratories, point-of-care settings, biotechnology and pharmaceutical companies, academic and research institutes, and other users. Central and reference laboratories account for a major share due to their capacity to perform high volumes of tests with stringent accuracy and reliability standards, aligning with national and international regulations for laboratory quality control. Point-of-care settings are experiencing rapid growth as healthcare systems increasingly prioritize immediate diagnostic solutions that enable prompt clinical decision-making, particularly in urgent care, remote, and rural environments. Biotechnology and pharmaceutical companies, along with academic research institutes, continue to adopt molecular diagnostics for research, clinical trials, and drug development, supported by government funding and policy frameworks aimed at accelerating innovation in healthcare diagnostics globally.
Nucleic Acid Amplification testing Market- Geographical Insights
The Nucleic Acid Amplification Testing (NAAT) market is primarily led by North America, which accounts for the largest share due to advanced healthcare infrastructure, substantial research and development investments, and a high prevalence of infectious diseases. The United States, in particular, benefits from strong government support, including funding for diagnostic innovation and public health programs, which drives adoption of NAAT across hospitals, laboratories, and point-of-care settings. The Asia-Pacific region is experiencing rapid growth, fueled by increasing healthcare expenditures, expanding diagnostic capacity, and a large population with diverse health challenges in countries such as China, India, Japan, and South Korea. Europe follows, supported by well-established healthcare systems, stringent regulatory frameworks, and government initiatives promoting molecular diagnostics. Latin America shows moderate growth, driven by improved healthcare access, awareness campaigns, and investments in infe
Nucleic Acid Amplification testing Market- Country Insights
The United States remains the leading market for Nucleic Acid Amplification Testing (NAAT), driven by advanced healthcare infrastructure, substantial investments in research and development, and a high prevalence of infectious diseases. The growing demand for rapid, accurate diagnostics has led to widespread adoption of NAAT across hospitals, clinical laboratories, and point-of-care facilities. Strong regulatory frameworks and government support for innovative diagnostic technologies further enhance market growth. Canada and Mexico also contribute to North America’s expanding NAAT market, with increasing healthcare spending, rising awareness of molecular diagnostics, and government initiatives promoting early disease detection and public health preparedness, reinforcing the region’s position as a global leader in nucleic acid-based testing.
Nucleic Acid Amplification testing Market- Competitive Landscape:
The Nucleic Acid Amplification Testing (NAAT) market is highly competitive, with leading players such as Roche, Abbott Laboratories, and Thermo Fisher Scientific driving innovation through comprehensive diagnostic solutions and extensive product portfolios. Companies like bioMérieux and Hologic specialize in infectious disease testing, leveraging advanced technologies and strategic collaborations to expand their market presence. QIAGEN and Bio-Rad Laboratories focus on assay development and molecular diagnostics, while Danaher capitalizes on strong R&D capabilities to fuel growth. Grifols S.A. and Seegene Inc. are also making notable advancements, contributing unique technologies and expanding their global footprint, thereby intensifying competition and fostering innovation in NAAT applications.
These companies prioritize technological innovation, portfolio expansion, and strategic partnerships to strengthen their global reach. For instance, in July 2025, South Korea-based Seegene Inc. launched its CURECA fully automated PCR testing system alongside the STAgora data analytics platform. CURECA is the world’s first system to fully automate the PCR testing process, including sample storage, pre-treatment, nucleic acid extraction, amplification, and result analysis, with no human intervention, representing a transformative shift in global diagnostics.
Recent Developments:
- In September 2024, Takara Bio USA, Inc. introduced the SmartChip ND Real-Time PCR System, an automated, high-throughput quantitative PCR (qPCR) solution for research-use-only (RUO). The system is designed to monitor antimicrobial resistance (AMR), addressing the growing global need for advanced tools in environmental safety and sustainability research.
- In December 2025, Roche launched the cobas BV/CV Assay, a new PCR-based diagnostic test that received CE Mark approval. This assay streamlines vaginitis diagnosis by using a single vaginal swab to rapidly and accurately detect bacteria responsible for bacterial vaginosis and yeast associated with candida vaginitis.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Roche (F. Hoffmann-La Roche Ltd.)
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- bioMérieux
- Hologic
- QIAGEN
- Bio-Rad Laboratories
- Danaher
- Grifols S.A.
- Seegene Inc.
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032
- Polymerase Chain Reaction (PCR) Tests
- Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Infectious Disease Testing
- Oncology Testing
- Genetic & Mitochondrial Disease Testing
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032
- Central and Reference Laboratories
- Point-of-Care Settings
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Nucleic Acid Amplification Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nucleic Acid Amplification Testing Market Snippet by Type
2.1.2. Nucleic Acid Amplification Testing Market Snippet by Application
2.1.3. Nucleic Acid Amplification Testing Market Snippet by End-use
2.1.4. Nucleic Acid Amplification Testing Market Snippet by Country
2.1.5. Nucleic Acid Amplification Testing Market Snippet by Region
2.2. Competitive Insights
3. Nucleic Acid Amplification Testing Key Market Trends
3.1. Nucleic Acid Amplification Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nucleic Acid Amplification Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nucleic Acid Amplification Testing Market Opportunities
3.4. Nucleic Acid Amplification Testing Market Future Trends
4. Nucleic Acid Amplification Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nucleic Acid Amplification Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Nucleic Acid Amplification Testing Market Landscape
6.1. Nucleic Acid Amplification Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nucleic Acid Amplification Testing Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
7.1.2. Polymerase Chain Reaction (PCR) Tests
7.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
7.1.4. Others
8. Nucleic Acid Amplification Testing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
8.1.2. Infectious Disease Testing
8.1.3. Oncology Testing
8.1.4. Genetic & Mitochondrial Disease Testing
8.1.5. Others
9. Nucleic Acid Amplification Testing Market – By End-use
9.1. Overview
9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
9.1.2. Infectious Disease Testing
9.1.3. Oncology Testing
9.1.4. Genetic & Mitochondrial Disease Testing
9.1.5. Others
10. Nucleic Acid Amplification Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Nucleic Acid Amplification Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3. Europe
10.3.1. Overview
10.3.2. Nucleic Acid Amplification Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Nucleic Acid Amplification TestingKey Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Nucleic Acid Amplification Testing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Nucleic Acid Amplification TestingKey Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Billion)
11. Key Vendor Analysis- Nucleic Acid Amplification Testing Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Roche (F. Hoffmann-La Roche Ltd.)
11.2.2. Abbott Laboratories
11.2.3. Thermo Fisher Scientific Inc.
11.2.4. bioMérieux
11.2.5. Hologic
11.2.6. QIAGEN
11.2.7. Bio-Rad Laboratories
11.2.8. Danaher
11.2.9. Grifols S.A.
11.2.10. Seegene Inc.
11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Roche (F. Hoffmann-La Roche Ltd.)
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- bioMérieux
- Hologic
- QIAGEN
- Bio-Rad Laboratories
- Danaher
- Grifols S.A.
- Seegene Inc.
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032
- Polymerase Chain Reaction (PCR) Tests
- Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Infectious Disease Testing
- Oncology Testing
- Genetic & Mitochondrial Disease Testing
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032
- Central and Reference Laboratories
- Point-of-Care Settings
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Others
GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
